These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 8809742)
1. An artificial thyroid hormone receptor mutant without DNA binding can have dominant negative effect. Liu RT; Suzuki S; Takeda T; DeGroot LJ Mol Cell Endocrinol; 1996 Jun; 120(1):85-93. PubMed ID: 8809742 [TBL] [Abstract][Full Text] [Related]
2. Very strong correlation between dominant negative activities of mutant thyroid hormone receptors and their binding avidity for corepressor SMRT. Matsushita A; Misawa H; Andoh S; Natsume H; Nishiyama K; Sasaki S; Nakamura H J Endocrinol; 2000 Dec; 167(3):493-503. PubMed ID: 11115777 [TBL] [Abstract][Full Text] [Related]
3. The dominant negative effect of thyroid hormone receptor splicing variant alpha 2 does not require binding to a thyroid response element. Liu RT; Suzuki S; Miyamoto T; Takeda T; Ozata M; DeGroot LJ Mol Endocrinol; 1995 Jan; 9(1):86-95. PubMed ID: 7760853 [TBL] [Abstract][Full Text] [Related]
4. The function of retinoid X receptors on negative thyroid hormone response elements. Takeda T; Nagasawa T; Miyamoto T; Hashizume K; DeGroot LJ Mol Cell Endocrinol; 1997 Apr; 128(1-2):85-96. PubMed ID: 9140079 [TBL] [Abstract][Full Text] [Related]
5. Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone beta-receptors in thyroid hormone resistance syndrome. Collingwood TN; Adams M; Tone Y; Chatterjee VK Mol Endocrinol; 1994 Sep; 8(9):1262-77. PubMed ID: 7838159 [TBL] [Abstract][Full Text] [Related]
6. Difference in dominant negative activities between mutant thyroid hormone receptors alpha1 and beta1 with an identical truncation in the extreme carboxyl-terminal tau4 domain. Nishiyama K; Andoh S; Kitahara A; Natsume H; Mikami T; Genma R; Nakamura H Mol Cell Endocrinol; 1998 Mar; 138(1-2):95-104. PubMed ID: 9685218 [TBL] [Abstract][Full Text] [Related]
7. Resistance to thyroid hormone caused by two mutant thyroid hormone receptors beta, R243Q and R243W, with marked impairment of function that cannot be explained by altered in vitro 3,5,3'-triiodothyroinine binding affinity. Yagi H; Pohlenz J; Hayashi Y; Sakurai A; Refetoff S J Clin Endocrinol Metab; 1997 May; 82(5):1608-14. PubMed ID: 9141558 [TBL] [Abstract][Full Text] [Related]
8. Modulation of thyroid hormone action by mutant thyroid hormone receptors, c-erbA alpha 2 and peroxisome proliferator-activated receptor: evidence for different mechanisms of inhibition. Meier-Heusler SC; Zhu X; Juge-Aubry C; Pernin A; Burger AG; Cheng SY; Meier CA Mol Cell Endocrinol; 1995 Jan; 107(1):55-66. PubMed ID: 7796935 [TBL] [Abstract][Full Text] [Related]
9. Amino acid substitutions of thyroid hormone receptor-beta at codon 435 with resistance to thyroid hormone selectively alter homodimer formation. Nomura Y; Nagaya T; Tsukaguchi H; Takamatsu J; Seo H Endocrinology; 1996 Oct; 137(10):4082-6. PubMed ID: 8828460 [TBL] [Abstract][Full Text] [Related]
11. N-terminal variants of thyroid hormone receptor beta: differential function and potential contribution to syndrome of resistance to thyroid hormone. Ng L; Forrest D; Haugen BR; Wood WM; Curran T Mol Endocrinol; 1995 Sep; 9(9):1202-13. PubMed ID: 7491112 [TBL] [Abstract][Full Text] [Related]
12. Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T3 response element-dependent dominant negative potency. Meier CA; Parkison C; Chen A; Ashizawa K; Meier-Heusler SC; Muchmore P; Cheng SY; Weintraub BD J Clin Invest; 1993 Oct; 92(4):1986-93. PubMed ID: 8408652 [TBL] [Abstract][Full Text] [Related]
13. Thyroid hormone receptor-beta mutants associated with generalized resistance to thyroid hormone show defects in their ligand-sensitive repression function. Piedrafita FJ; Ortiz MA; Pfahl M Mol Endocrinol; 1995 Nov; 9(11):1533-48. PubMed ID: 8584031 [TBL] [Abstract][Full Text] [Related]
14. Cell type-dependent modulation of the dominant negative action of human mutant thyroid hormone beta 1 receptors. Wong R; Zhu XG; Pineda MA; Cheng SY; Weintraub BD Mol Med; 1995 Mar; 1(3):306-19. PubMed ID: 8529109 [TBL] [Abstract][Full Text] [Related]
15. Protein-protein interaction domains and the heterodimerization of thyroid hormone receptor variant alpha2 with retinoid X receptors. Wu Y; Yang YZ; Koenig RJ Mol Endocrinol; 1998 Oct; 12(10):1542-50. PubMed ID: 9773977 [TBL] [Abstract][Full Text] [Related]
16. Dominant negative and DNA-binding properties of mutant thyroid hormone receptors that are defective in homodimerization but not heterodimerization. Kitajima K; Nagaya T; Jameson JL Thyroid; 1995 Oct; 5(5):343-53. PubMed ID: 8563470 [TBL] [Abstract][Full Text] [Related]
17. Requirement of corepressor binding of thyroid hormone receptor mutants for dominant negative inhibition. Nagaya T; Fujieda M; Seo H Biochem Biophys Res Commun; 1998 Jun; 247(3):620-3. PubMed ID: 9647743 [TBL] [Abstract][Full Text] [Related]
18. Differences between the silencing-related properties of the extreme carboxyl-terminal regions of thyroid hormone receptors alpha 1 and beta 1. Nishiyama K; Matsushita A; Natsume H; Mikami T; Genma R; Sasaki S; Nakamura H J Endocrinol; 2000 Nov; 167(2):219-27. PubMed ID: 11054635 [TBL] [Abstract][Full Text] [Related]
19. Nuclear corepressors enhance the dominant negative activity of mutant receptors that cause resistance to thyroid hormone. Tagami T; Jameson JL Endocrinology; 1998 Feb; 139(2):640-50. PubMed ID: 9449636 [TBL] [Abstract][Full Text] [Related]
20. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation. Raval-Pandya M; Freedman LP; Li H; Christakos S Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]